| Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer (NCT04033419) | UNC Lineberger Comprehensive Cancer Center | 2019-09-25 |
| Factor Replacement in Surgery (NCT04114643) | University Health Network, Toronto | 2019-09-24 |
| Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease (NCT04617860) | Wave Life Sciences USA, Inc. | 2019-09-24 |
| Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma (NCT04080154) | Shanghai Zhongshan Hospital | 2019-09-24 |
| Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma (NCT03991962) | Yale University | 2019-09-24 |
| PDE6A Gene Therapy for Retinitis Pigmentosa (NCT04611503) | STZ eyetrial | 2019-09-24 |
| The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus (NCT03656666) | Oslo University Hospital | 2019-09-24 |
| A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032 (NCT04086121) | Boehringer Ingelheim | 2019-09-24 |
| A Pilot Study of Terazosin for Parkinson's Disease (NCT03905811) | Jordan Schultz | 2019-09-24 |
| A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients (NCT03973112) | Shanghai Henlius Biotech | 2019-09-24 |
| Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment (NCT04106414) | Memorial Sloan Kettering Cancer Center | 2019-09-24 |
| A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine (NCT04153409) | Lateral Pharma Pty Ltd | 2019-09-24 |
| A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma (NCT04038359) | SecuraBio | 2019-09-24 |
| Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers (NCT04111380) | Henan Provincial People's Hospital | 2019-09-24 |
| Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong (NCT04091139) | Chinese University of Hong Kong | 2019-09-24 |
| Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old (NCT04122170) | SFJ Pharmaceuticals, Inc. | 2019-09-24 |
| A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. (NCT04019561) | MedImmune LLC | 2019-09-23 |
| Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy (NCT03872388) | M.D. Anderson Cancer Center | 2019-09-23 |
| Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis (NCT03996291) | Sanofi | 2019-09-23 |
| A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease (NCT04102111) | Janssen Research & Development, LLC | 2019-09-23 |
| Safety and Efficacy Study of IMSA101 in Refractory Malignancies (NCT04020185) | ImmuneSensor Therapeutics Inc. | 2019-09-23 |
| Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation (NCT04035200) | Imbrium Therapeutics | 2019-09-23 |
| A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis (NCT04131309) | Stichting European Myeloma Network | 2019-09-23 |
| Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer (NCT03917082) | British Columbia Cancer Agency | 2019-09-23 |
| Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau (NCT03907657) | UNC Lineberger Comprehensive Cancer Center | 2019-09-23 |
| The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% (NCT04212429) | National University of Malaysia | 2019-09-23 |
| The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5% (NCT04214821) | National University of Malaysia | 2019-09-23 |
| Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission (NCT03376477) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-09-23 |
| A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy (NCT04072380) | Suven Life Sciences Limited | 2019-09-21 |
| Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib (NCT04079738) | H Scott Boswell | 2019-09-20 |
| sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT04033432) | Northwestern University | 2019-09-20 |
| Thromboxane Receptor Antagonist to Improve Endothelial Function (NCT03962855) | Jeffrey Rade | 2019-09-20 |
| A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI (NCT04023266) | University of Alberta | 2019-09-20 |
| Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy (NCT03847467) | Children's Hospital Medical Center, Cincinnati | 2019-09-20 |
| Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC (NCT04066491) | EMD Serono Research & Development Institute, Inc. | 2019-09-20 |
| Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (NCT03781063) | Sermonix Pharmaceuticals Inc. | 2019-09-20 |
| Flunarizine for Treatment Resistant Absence Epilepsy (NCT06153186) | University of British Columbia | 2019-09-20 |
| 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. (NCT03988933) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2019-09-20 |
| Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT03817190) | DS Biopharma | 2019-09-19 |
| Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) (NCT04003103) | Merck Sharp & Dohme LLC | 2019-09-19 |
| Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer (NCT03853187) | Radboud University Medical Center | 2019-09-19 |
| A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS) (NCT04079296) | Astellas Pharma Global Development, Inc. | 2019-09-19 |
| A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) (NCT03940703) | EMD Serono Research & Development Institute, Inc. | 2019-09-19 |
| Arbaclofen in Children and Adolescents With ASD (NCT03682978) | Celso Arango, MD, PhD | 2019-09-19 |
| Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer (NCT03942328) | Mayo Clinic | 2019-09-19 |
| Ketamine or Placebo in Patients With Major Depression and Advanced Cancer (NCT04471818) | Instituto Nacional de Cancerologia de Mexico | 2019-09-19 |
| Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc) (NCT04137224) | CSL Behring | 2019-09-19 |
| A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. (NCT04104685) | Vyne Therapeutics Inc. | 2019-09-18 |
| Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (NCT04186013) | Spanish Oncology Genito-Urinary Group | 2019-09-18 |
| A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas (NCT04104776) | Novartis Pharmaceuticals | 2019-09-18 |
| Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass (NCT03984370) | University Hospital, Gentofte, Copenhagen | 2019-09-18 |
| CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC) (NCT03904719) | AnewPharma | 2019-09-18 |
| Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease (NCT04088734) | Ultragenyx Pharmaceutical Inc | 2019-09-18 |
| Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial (NCT03841084) | Australian and New Zealand Intensive Care Research Centre | 2019-09-18 |
| Ixazomib + Pomalidomide + Dexamethasone In MM (NCT04094961) | Omar Nadeem, MD | 2019-09-18 |
| Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury (NCT03945110) | The University of Western Australia | 2019-09-18 |
| GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors (NCT04083599) | Genmab | 2019-09-17 |
| A Study of JNJ-61393215 in the Treatment of Depression (NCT04080752) | Janssen Research & Development, LLC | 2019-09-17 |
| Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects (NCT04087707) | Taisho Pharmaceutical Co., Ltd. | 2019-09-17 |
| TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer (NCT04094896) | Guangdong Provincial People's Hospital | 2019-09-17 |
| Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT) (NCT04095234) | Memorial Sloan Kettering Cancer Center | 2019-09-17 |
| The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients. (NCT03905447) | Pulmocide Ltd | 2019-09-17 |
| Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis (NCT04002141) | University of California, San Francisco | 2019-09-17 |
| Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer (NCT04101812) | Tianjin Medical University Second Hospital | 2019-09-17 |
| A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and Rhabdomyosarcoma (NCT04095221) | Memorial Sloan Kettering Cancer Center | 2019-09-17 |
| Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (NCT04011618) | University of Guadalajara | 2019-09-17 |
| Effect of Pumpkin Seeds in the Treatment of Moderate to Severe Palmar Arsenical Keratosis (NCT04608461) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2019-09-17 |
| UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (NCT03933410) | Kaleido Biosciences | 2019-09-17 |
| The Trauma INtramuscular Tranexamic Acid Clinical Trial (NCT03875937) | London School of Hygiene and Tropical Medicine | 2019-09-17 |
| Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients (NCT04001413) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-09-17 |
| CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma (NCT04083495) | UNC Lineberger Comprehensive Cancer Center | 2019-09-17 |
| A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1 (NCT04059094) | Boehringer Ingelheim | 2019-09-16 |
| FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test (NCT06193525) | Erasmus Medical Center | 2019-09-16 |
| Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy  (NCT04933357) | National Cancer Institute, Egypt | 2019-09-16 |
| APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant (NCT03931291) | Aprea Therapeutics | 2019-09-16 |
| Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA) (NCT04184063) | EmeraMed | 2019-09-16 |
| Transfusion of Biotin-Labeled Red Blood Cells (NCT03364686) | Gladwin, Mark, MD | 2019-09-16 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa (NCT04019041) | Janssen Research & Development, LLC | 2019-09-16 |
| Cannabidiol as a Treatment for AUD Comorbid With PTSD (NCT03248167) | NYU Langone Health | 2019-09-16 |
| Sirolimus for Cowden Syndrome With Colon Polyposis (NCT04094675) | Ohio State University | 2019-09-16 |
| A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma (NCT03802071) | Yonsei University | 2019-09-16 |
| Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa (NCT02644525) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-09-16 |
| TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders (NCT04088760) | Children's Hospital Medical Center, Cincinnati | 2019-09-16 |
| Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene. (NCT03887169) | Assistance Publique - Hôpitaux de Paris | 2019-09-16 |
| Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft (NCT03887156) | Assistance Publique - Hôpitaux de Paris | 2019-09-16 |
| Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke (NCT04419337) | Chang Gung Memorial Hospital | 2019-09-15 |
| Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries (NCT03960970) | RWJ Barnabas Health at Jersey City Medical Center | 2019-09-15 |
| Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells (NCT04082910) | Chinese PLA General Hospital | 2019-09-15 |
| A Clinical Pharmacology Study of K-877 Controlled Release Tablet (NCT04079530) | Kowa Company, Ltd. | 2019-09-13 |
| Growth Hormone Treatment in Children With Phelan McDermid Syndrome (NCT04003207) | Swathi Sethuram | 2019-09-13 |
| The Use of Trifluoperazine in Transfusion Dependent DBA (NCT03966053) | Adrianna Vlachos, MD | 2019-09-13 |
| COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC (NCT04068610) | MedImmune LLC | 2019-09-13 |
| Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC (NCT04060394) | Laekna Limited | 2019-09-13 |
| AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission (NCT04062266) | M.D. Anderson Cancer Center | 2019-09-13 |
| Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT04052997) | ADC Therapeutics S.A. | 2019-09-13 |
| A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT) (NCT04528706) | Minoryx Therapeutics, S.L. | 2019-09-13 |
| Antidepressant Trial With P2X7 Antagonist JNJ-54175446 (NCT04116606) | CCTU-Core | 2019-09-12 |
| Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease (NCT04031729) | Massachusetts General Hospital | 2019-09-12 |
| Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears (NCT04088227) | Andrews Research & Education Foundation | 2019-09-12 |
| Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission (NCT04049916) | London School of Hygiene and Tropical Medicine | 2019-09-12 |